Lupin gets U.S. FDA nod for biosimilar
The product will be manufactured at the company’s biotech facility in Pune, which was inspected by the U.S. FDA prior to approval, Lupin said on Monday. “We are proud to…
Lupin launches generic injection in US with 180-day exclusivity
The company has launched Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, single-dose vials Drug maker Lupin on Friday said…
Lupin receives US FDA approval for its generic cancer drug
Indian pharma major Lupin announced that the US Food and Drug Administration has approved its abbreviated new drug application for Lenalidomide capsules in strengths of 2.5 mg to 25 mg…
Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
Lupin launches Ipratropium Bromide nasal spray in US
Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal…
Lupin to boost complex generics in US, EU; eyes chronic growth in India
Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…
Lupin launches cardiovascular drug in US market
Lupin : It launched generic heart rivaroxaban tablets in the US market after it received approval from the US Food and Drug Administration (US FDA). According to the company, the…
Lupin receives US FDA Establishment Inspection Report for Somerset facility
Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey.…
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%
Share of pharma companies saw red on February 14 as caution over the possibility of US tariffs hitting the sector spread across the Street. This came after US President Donald…
CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged
The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023. The drug regulator’s…
